|
|
|
|
|
|
|
|
|
|
"The test will require FDA approval before it can move beyond clinical testing.Pathologists and oncologists already have a test, called CellSearch, that’s used to look for CTCs (circulating tumor cells). But Kuhn says physicians need a test that is far more sensitive, and thus more useful for a wide array of cancer patients."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.